Jackson Square Partners, LLC Tandem Diabetes Care Inc Transaction History

Jackson Square Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$53.22 - $123.09 $79.8 Million - $185 Million	-1,499,740 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$101.89 - $150.09 $102 Million - $151 Million	-1,004,606 Reduced 40.11%	1,499,740 $174 Million
Q4 2021 Feb 14, 2022	SELL	$118.18 - $153.21 $126 Million - $164 Million	-1,067,292 Reduced 29.88%	2,504,346 $377 Million
Q3 2021 Nov 12, 2021	SELL	$93.51 - $129.4 $4.81 Million - $6.66 Million	-51,456 Reduced 1.42%	3,571,638 $426 Million
Q2 2021 Aug 13, 2021	SELL	$77.0 - $100.19 $6.37 Million - $8.29 Million	-82,718 Reduced 2.23%	3,623,094 $353 Million
Q1 2021 May 13, 2021	BUY	$81.28 - $104.34 $42.2 Million - $54.1 Million	518,825 Added 16.28%	3,705,812 $327 Million
Q4 2020 Feb 12, 2021	BUY	$86.4 - $121.75 $275 Million - $388 Million	3,186,987 New	3,186,987 $305 Million

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.97B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Jackson Square Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Square Partners, LLC with notifications on news.